New FDA guidance on off-label promotion falls short for everyone: obama administration is likely to revisit it. [electronic resource]
Producer: 20121002Description: 122-3 p. digitalISSN:- 1052-1372
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.